Literature DB >> 7683582

Rapid analysis of hemoglobin variants by cation-exchange HPLC.

C N Ou1, C L Rognerud.   

Abstract

We investigated the use of a 3.5 x 0.46 cm HPLC column packed with 5-microns particles of porous (100 nm) silica coated with polyaspartic acid for hemoglobin analysis. A 13-min gradient was produced between two mobile phases. The method is capable of separating more than 35 commonly encountered hemoglobin variants within 12 min. Hemoglobin variants identified include Bart's, acetyl F, H, A1c, F, Camden, N-Baltimore, J-Baltimore, N-Seattle, Grady, Fannin-Lubbock, A G-Georgia, Lepore-Baltimore, P-Galveston, G-Coushatta, Lepore-Boston, E, Osu Christiansborg, A2, G-Philadelphia, Korle Bu, Russ, Richmond, D-Los Angeles, Deer Lodge, Montgomery, S, Q-Thailand, G-San Jose, A2', Hasharon, Q-India, Tampa, GS hybrid, C-Harlem, O-Arab, British Columbia, and C. Between-run precision of an in-house pooled hemoglobin control material, AFSCA2, gave CVs of 2-5% for the A, F, S, and C and 8% for the A2 over a 6-month period. The simplicity of sample preparation, high resolution of the system, and high accuracy of the method, combined with complete automation, make this an ideal methodology for the routine diagnosis of hemoglobin disorders in a clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683582

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  16 in total

1.  Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation.

Authors:  Rodwell Mabaera; Christine A Richardson; Kristin Johnson; Mei Hsu; Steven Fiering; Christopher H Lowrey
Journal:  Blood       Date:  2007-04-24       Impact factor: 22.113

2.  Utility of family studies in diagnosing abnormal hemoglobins/thalassemic states.

Authors:  Aruna Rangan; A Handoo; S Sinha; R Saxena; I C Verma; S Kumar; S K Sood; M Bhargava
Journal:  Indian J Pediatr       Date:  2009-04-23       Impact factor: 1.967

3.  Characterization of a hemoglobin variant: HbQ-India / IVS 1-1 [G>T]-β-thalassemia.

Authors:  Vijay S Bhat; K K Dewan; P R Krishnaswamy; A K Mandal; P Balaram
Journal:  Indian J Clin Biochem       Date:  2010-02-10

4.  Reactivation of developmentally silenced globin genes by forced chromatin looping.

Authors:  Wulan Deng; Jeremy W Rupon; Ivan Krivega; Laura Breda; Irene Motta; Kristen S Jahn; Andreas Reik; Philip D Gregory; Stefano Rivella; Ann Dean; Gerd A Blobel
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

5.  Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports.

Authors:  Nicola Lamberti; Alessia Finotti; Jessica Gasparello; Ilaria Lampronti; Christel Zambon; Lucia Carmela Cosenza; Enrica Fabbri; Nicoletta Bianchi; Francesca Dalla Corte; Maurizio Govoni; Roberto Reverberi; Roberto Gambari; Fabio Manfredini
Journal:  Intern Emerg Med       Date:  2018-03-23       Impact factor: 3.397

6.  Hemoglobin variants identified in the Uganda Sickle Surveillance Study.

Authors:  Beverly A Schaefer; Charles Kiyaga; Thad A Howard; Grace Ndeezi; Arielle G Hernandez; Isaac Ssewanyana; Mary C Paniagua; Christopher M Ndugwa; Jane R Aceng; Russell E Ware
Journal:  Blood Adv       Date:  2016-11-22

7.  Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.

Authors:  Michael S Boosalis; Serguei A Castaneda; Marie Trudel; Rodwell Mabaera; Gary L White; Christopher H Lowrey; David W Emery; Marthe-Sandrine Eiymo Mwa Mpollo; Ling Shen; William A Wargin; Regine Bohacek; Douglas V Faller; Susan P Perrine
Journal:  Blood Cells Mol Dis       Date:  2011-08-15       Impact factor: 3.039

8.  Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.

Authors:  Elizabeth R Macari; Emily K Schaeffer; Rachel J West; Christopher H Lowrey
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

9.  Familial polycythemia caused by a novel mutation in the beta globin gene: essential role of P50 in evaluation of familial polycythemia.

Authors:  Neeraj Agarwal; Mariluz P Mojica-Henshaw; Elizabeth D Simmons; Dottie Hussey; Ching N Ou; Josef T Prchal
Journal:  Int J Med Sci       Date:  2007-10-04       Impact factor: 3.738

10.  Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

Authors:  Robert M Cohen; Robert S Franco; Paramjit K Khera; Eric P Smith; Christopher J Lindsell; Peter J Ciraolo; Mary B Palascak; Clinton H Joiner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.